XD益丰药
(603939)
| 流通市值：282.61亿 | | | 总市值：282.61亿 |
| 流通股本：12.12亿 | | | 总股本：12.12亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 12,129,983,982.07 | 6,085,003,538.59 | 24,433,165,197.5 | 17,285,899,932.64 |
| 营业总成本 | 10,737,842,732.39 | 5,386,162,931.81 | 22,129,134,049.16 | 15,631,502,380.85 |
| 其他经营收益 | | | | |
| 营业利润 | 1,446,642,520.67 | 727,664,900.37 | 2,453,723,769.8 | 1,786,801,453.44 |
| 利润总额 | 1,441,769,394.05 | 723,639,787.14 | 2,456,394,852.41 | 1,769,955,687.28 |
| 净利润 | 1,069,067,642.08 | 546,085,134.16 | 1,831,025,556.6 | 1,321,166,607.72 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | 75,076,268.99 | 47,773,490.51 |
| 综合收益总额 | 1,069,067,642.08 | 546,085,134.16 | 1,906,101,825.59 | 1,368,940,098.23 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 15,548,141,073.62 | 16,388,210,229.75 | 16,825,997,154.25 | 15,089,934,116.45 |
| 非流动资产: | | | | |
| 非流动资产合计 | 10,281,052,358.61 | 10,447,144,268.21 | 10,625,926,894.33 | 10,981,452,997.05 |
| 资产总计 | 25,829,193,432.23 | 26,835,354,497.96 | 27,451,924,048.58 | 26,071,387,113.5 |
| 流动负债: | | | | |
| 流动负债合计 | 9,703,566,118.65 | 10,656,988,771.62 | 11,752,772,950.11 | 10,612,983,485.72 |
| 非流动负债: | | | | |
| 非流动负债合计 | 3,165,700,439.78 | 3,258,803,928.91 | 3,320,542,814.71 | 3,575,961,193.19 |
| 负债合计 | 12,869,266,558.43 | 13,915,792,700.53 | 15,073,315,764.82 | 14,188,944,678.91 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 12,117,509,052.36 | 12,133,848,482.5 | 11,634,287,444.84 | 11,177,628,791.76 |
| 股东权益合计 | 12,959,926,873.8 | 12,919,561,797.43 | 12,378,608,283.76 | 11,882,442,434.59 |
| 负债和股东权益合计 | 25,829,193,432.23 | 26,835,354,497.96 | 27,451,924,048.58 | 26,071,387,113.5 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 13,583,319,778.94 | 7,013,341,234.55 | 26,303,555,418.05 | 19,349,072,108.88 |
| 经营活动现金流出小计 | 12,129,760,144.27 | 5,956,969,996.44 | 22,945,107,403.64 | 17,081,861,091.07 |
| 经营活动产生的现金流量净额 | 1,453,559,634.67 | 1,056,371,238.11 | 3,358,448,014.41 | 2,267,211,017.81 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 11,106,020,077.87 | 5,121,166,287.98 | 24,251,873,963.89 | 22,618,211,396.5 |
| 投资活动现金流出小计 | 10,538,304,054.45 | 5,427,070,017.78 | 25,678,052,852.81 | 22,981,387,474.34 |
| 投资活动产生的现金流量净额 | 567,716,023.42 | -305,903,729.8 | -1,426,178,888.92 | -363,176,077.84 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | - | - | 1,762,800 | 1,753,000 |
| 筹资活动现金流出小计 | 1,158,536,808.44 | 328,357,053.98 | 2,481,561,351.78 | 2,077,528,121.25 |
| 筹资活动产生的现金流量净额 | -1,158,536,808.44 | -328,357,053.98 | -2,479,798,551.78 | -2,075,775,121.25 |
| 汇率变动对现金及现金等价物的影响 | - | - | - | - |
| 现金及现金等价物净增加额 | 862,738,849.65 | 422,110,454.33 | -547,529,426.29 | -171,740,181.28 |
| 期末现金及现金等价物余额 | 2,476,007,293.88 | 2,035,378,898.56 | 1,613,268,444.23 | 1,989,057,689.24 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 862,738,849.65 | - | -547,529,426.29 | - |
最新报告期：2026-09-21| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 东海证券 | 杜永宏 | 1.59 | 1.79 | 2.03 | 2026-09-21 |
| 东方证券 | 伍云飞,袁润璞 | 1.53 | 1.76 | 1.89 | 2026-09-20 |
| 中邮证券 | 盛丽华,龙永茂 | 1.53 | 1.73 | 1.99 | 2026-09-08 |
| 中信建投 | 刘若飞,沈兴熙,贺菊颖 | 1.57 | 1.81 | 2.08 | 2026-09-06 |
| 光大证券 | 黄素青 | 1.58 | 1.79 | 1.99 | 2026-09-03 |